|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 4/23/19 Procter & Gamble Co 10-Q 3/31/19 71:6.9M |
Document/Exhibit Description Pages Size
1: 10-Q FY 1819 Q3 Jfm 10-Q HTML 620K
2: EX-10.1 The Procter & Gamble Performance Stock Program HTML 109K
Summary
3: EX-31.1 Exhibit 31.1 Rule 13A-14(A)/15D-14(A) HTML 30K
Certification Chief Executive Officer
4: EX-31.2 Exhibit 31.2 Rule 13A-14(A)/15D-14(A) HTML 30K
Certification Chief Executive Officer
5: EX-32.1 Section 1350 Certification Chief Executive Officer HTML 25K
6: EX-32.2 Section 1350 Certification-Chief Financial Officer HTML 25K
13: R1 Document and Entity Information HTML 49K
14: R2 Consolidated Statements of Earnings HTML 79K
15: R3 Condolidated Statements of Comprehensive Income HTML 53K
16: R4 Consolidated Balance Sheets HTML 123K
17: R5 Consolidated Statements of Cash Flows HTML 102K
18: R6 CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY HTML 100K
Consolidated Statements of Shareholders' Equity
QTD
19: R7 CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY HTML 102K
Consolidated Statements of Shareholders' Equity
FYTD
20: R8 CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY HTML 89K
Consolidated Statements of Shareholders' Equity PY
QTD
21: R9 CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY HTML 89K
Consolidated Statements of Shareholders' Equity PY
YTD
22: R10 Basis of Presentation HTML 27K
23: R11 New Accounting Pronouncements and Policies HTML 40K
24: R12 Segment Information HTML 119K
25: R13 Goodwill and Other Intangible Assets HTML 69K
26: R14 Earnings Per Share HTML 75K
27: R15 Share-Based Compensation and Postretirement HTML 41K
Benefits
28: R16 Risk Management Activities and Fair Value HTML 112K
Measurements
29: R17 Accumulated Other Comprehensive Income (Loss) HTML 61K
30: R18 Restructuring Program HTML 70K
31: R19 Commitments and Contingencies HTML 29K
32: R20 Acquisition HTML 55K
33: R21 Segment Information (Tables) HTML 117K
34: R22 Goodwill and Other Intangible Assets (Tables) HTML 64K
35: R23 Earnings Per Share (Tables) HTML 74K
36: R24 Share-Based Compensation and Postretirement HTML 39K
Benefits (Tables)
37: R25 Risk Management Activities and Fair Value HTML 116K
Measurements (Tables)
38: R26 Accumulated Other Comprehensive Income (Loss) HTML 59K
(Tables)
39: R27 Restructuring Program (Tables) HTML 68K
40: R28 Acquisition - Allocation of Purchase Price HTML 38K
(Tables)
41: R29 Acquisition - Fair Value of Intangibles (Tables) HTML 36K
42: R30 Summary of Significant Accounting Policies - HTML 34K
Additional Information (Details)
43: R31 New Accounting Pronouncements and Policies - U.S. HTML 42K
Tax Reform (Details)
44: R32 Segment Information Segment Information - Sales HTML 51K
(Details)
45: R33 Segment Information (Details) HTML 51K
46: R34 Goodwill and Other Intangible Assets - Change in HTML 45K
the Net Carrying Amount of Goodwill by Global
Business Unit (Details)
47: R35 Goodwill and Other Intangible Assets - HTML 32K
Identifiable Intangible Assets (Details)
48: R36 Goodwill and Other Intangible Assets - Additional HTML 38K
Information (Details)
49: R37 Goodwill and Other Intangible Assets - Fair Value HTML 34K
Sensitivity (Details)
50: R38 Earnings Per Share (Details) HTML 69K
51: R39 Earnings Per Share - Antidilutive Securities HTML 29K
(Details)
52: R40 Share-Based Compensation and Postretirement HTML 37K
Benefits (Details)
53: R41 Risk Management Activities and Fair Value HTML 29K
Measurements - Assets and Liabilities Measured on
A Recurring Basis (Details)
54: R42 Risk Management Activities and Fair Value HTML 45K
Measurements - Schedule of Derivative Instruments
(Details)
55: R43 Risk Management Activities and Fair Value HTML 37K
Measurements - Derivative Instruments, Effect on
Other Comprehensive Income (Loss) (Details)
56: R44 Risk Management Activities and Fair Value HTML 28K
Measurements - Derivative Instruments, Effect on
Other Comprehensive Income (Loss) - Additional
Information (Details)
57: R45 Risk Management Activities and Fair Value HTML 32K
Measurements - Derivative Instruments Gain (Loss)
(Details)
58: R46 Risk Management Activities and Fair Value HTML 46K
Measurements - Additional Information (Details)
59: R47 Accumulated Other Comprehensive Income (Loss) - HTML 64K
Changes in Aoci and Reclassification Out of Aoci
(Details)
60: R48 Accumulated Other Comprehensive Income (Loss) - HTML 35K
Net of Tax Expense (Benefit) (Details)
61: R49 Restructuring Program - Additional Information HTML 38K
(Details)
62: R50 Restructuring Program - Restructuring Reserve by HTML 47K
Type of Costs (Details)
63: R51 Restructuring Program - Restructuring Costs Per HTML 42K
Segment (Details)
64: R52 Commitments and Contingencies - Additional HTML 29K
Information (Details)
65: R53 Acquisition - Allocation of Purchase Price HTML 59K
(Details)
66: R54 Acquisition Acquisition - Fair Value of HTML 45K
Intangibles (Details)
67: R55 Acquisition - Additional Information (Details) HTML 61K
68: R9999 Uncategorized Items - pg-20190331.xml HTML 89K
70: XML IDEA XML File -- Filing Summary XML 127K
69: EXCEL IDEA Workbook of Financial Reports XLSX 72K
7: EX-101.INS XBRL Instance -- pg-20190331 XML 2.06M
9: EX-101.CAL XBRL Calculations -- pg-20190331_cal XML 164K
10: EX-101.DEF XBRL Definitions -- pg-20190331_def XML 773K
11: EX-101.LAB XBRL Labels -- pg-20190331_lab XML 1.18M
12: EX-101.PRE XBRL Presentations -- pg-20190331_pre XML 915K
8: EX-101.SCH XBRL Schema -- pg-20190331 XSD 131K
71: ZIP XBRL Zipped Folder -- 0000080424-19-000031-xbrl Zip 191K
| Exhibit |
(1) | The Quarterly Report on Form 10-Q of the Company for the quarterly period ended March 31,
2019 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | The information contained in that Form 10-Q fairly presents, in all material respects, the financial conditions and results of operations of the Company. |
/s/ JON
R. MOELLER |
Vice Chairman and Chief Financial Officer |
Date |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 4/23/19 | 8-K | ||
| For Period end: | 3/31/19 | |||
| List all Filings | ||||